IP Library Granted Patent US 10,641,764
Granted Patent B2
US 10,641,764 · App. 15/741,103 · Granted May 5, 2020

Membrane and droplet-interface bilayer systems and methods

Inventors: Matthew A. Holden (Amherst, MA); Max J. Lein (Belmont, MA); Arash Manafirad (Amherst, MA); Dan Ezra Aurian-Blajeni (Newport, RI)
Assignee: THE UNIVERSITY OF MASSACHUSETTS
G01N33/5432B01J13/08G01N33/6872G01N2500/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,641,764
App. No.
15/741,103
Granted
May 5, 2020
Kind
B2
Abstract

Droplet-interface bilayer and lipid bilayer membrane compositions stabilized with an amphiphilic polymer are disclosed. Methods of making and using the compositions are also disclosed.

Claims (14)

1. A system comprising

a bilayer of amphipathic molecules provided at the interface between

a first droplet of a first aqueous solution in a hydrophobic medium, the first droplet comprising a layer of amphipathic molecules around the surface of the first aqueous solution, and containing a eukaryotic transcription/translation extract and a heterologous polynucleotide encoding a membrane polypeptide; and

a second droplet of a second aqueous solution in the hydrophobic medium, the second droplet comprising a layer of amphipathic molecules around the surface of the second aqueous solution;

wherein the bilayer contains a polymer and the membrane polypeptide synthesized within the first droplet from the heterologous polynucleotide by the eukaryotic transcription/translation extract.

2. The system of claim 1 , wherein the membrane polypeptide is a channel or a pore.

3. The system of claim 1 , wherein the hydrophobic medium is oil.

4. The pair of droplets of claim 1 , wherein the amphipathic molecules are lipid molecules.

5. The system of claim 1 , wherein each droplet has a volume of at least about 20 pL and less than about 1000 nL.

6. The system of claim 1 , wherein the polymer is a silicone.

7. The system of claim 1 , wherein the first or second droplet contains a test compound, a polypeptide, a polymer, or a combination thereof.

8. The system of claim 1 , wherein the bilayer is stable for at least about 30 minutes.

9. The system of claim 1 , wherein the polymer is present in the first or second aqueous solution.

10. The system of claim 1 , wherein the membrane polypeptide is a eukaryotic polypeptide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2018
From: HOLDEN, MATTHEW A.; LEIN, MAX J.; MANAFIRAD, ARASH; AURIAN-BLAJENI, DAN EZRA
To: THE UNIVERSITY OF MASSACHUSETTS
Reel/Frame 044513/0639 →
Continuity (2)
Provisional Application 62187951 · Jul 2, 2015
Related Publication 20180196040A1 · Jul 12, 2018